Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam (Q39571405)
Jump to navigation
Jump to search
scientific article published on 6 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam |
scientific article published on 6 August 2012 |
Statements
1 reference
Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam (English)
1 reference
Susanne Schoch
1 reference
Christoph Helmstaedter
1 reference
Yoan Mihov
1 reference
Mohammad R Toliat
1 reference
Holger Thiele
1 reference
Peter Nuernberg
1 reference
Christian E Elger
1 reference
6 August 2012
1 reference
1 reference
54
1 reference
1
1 reference
36-44
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference